title: Chlorpromazine for psychosis induced aggression or agitation.
abstract: BACKGROUND
  Agitated or violent behaviour constitutes 10% of all emergency psychiatric treatment. Some guidelines do not recommend the use of chlorpromazine for rapid tranquillisation but it is still often used for this purpose.
  
  
  OBJECTIVE
  To examine the effects of oral or intramuscular chlorpromazine for psychosis induced agitation or aggression.
  
  
  METHODS
  We searched the Cochrane Schizophrenia Group Trials Register (up to July 2009) which is based on regular searches of CINAHL, EMBASE, MEDLINE and PsycINFO.
  
  
  METHODS
  Randomised control trials or double blind trials (implying randomisation) comparing chlorpromazine with another drug or placebo for people who are thought to be acutely aggressive or agitated due to psychotic illness.
  
  
  METHODS
  We extracted data independently. For dichotomous data we calculated relative risks (RR) and their 95% confidence intervals (CI) on an intention-to-treat basis based on a fixed-effects model.
  
  
  RESULTS
  One study (total n=30) met the inclusion criteria. When compared with haloperidol (Man 1973) (1 RCT, n=30) people allocated chlorpromazine were no more likely to have one additional injection than those allocated haloperidol (RR 3.00 CI 0.13 to 68.26). This remained true for 2-4 injections (RR 0.90 CI 0.52 to 1.55) and for 5 or more injections (RR 0.75 CI 0.20 to 2.79). Two people allocated chlorpromazine had sudden, serious hypotension while no one allocated haloperidol had such an effect (RR 5.00 CI 0.26 to 96.13). No extrapyramidal symptoms were observed. One person allocated chlorpromazine developed status epilepticus (RR 3.00 CI 0.13 to 68.26).
  
  
  CONCLUSIONS
  Overall the quality of evidence is limited, poor and dated. Where drugs that have been better evaluated are available, it may be best to avoid use of chlorpromazine. Where chlorpromazine is used for acute aggression or where choices are limited, relevant trials are possible and urgently needed.
authors.affiliation: Parkside Lodge, Leeds PFT, Leeds, UK, LS12 2AE.
authors.forename: Uzair
authors.initials: U
authors.lastname: Ahmed
authors.forename: Hannah
authors.initials: H
authors.lastname: Jones
authors.forename: Clive E
authors.initials: CE
authors.lastname: Adams
mesh_terms: D000284:Administration, Oral; D000374:Aggression / Q000187:drug effects* / Q000523:psychology; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D002746:Chlorpromazine / Q000008:administration & dosage*; D006220:Haloperidol / Q000008:administration & dosage; D006801:Humans; D007273:Injections, Intramuscular; D011595:Psychomotor Agitation / Q000188:drug therapy*; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000523:psychology
chemical_list: D014150:Antipsychotic Agents; D006220:Haloperidol; D002746:Chlorpromazine
references.citation: Stat Med. 2002 Jun 15;21(11):1539-58
references.pmid: 12111919
references.citation: Cochrane Database Syst Rev. 2009 Jul 08;(3):CD005146
references.pmid: 19588366
references.citation: Cochrane Database Syst Rev. 2008 Jan 23;(1):CD004278
references.pmid: 18254045
references.citation: BMJ. 1997 Sep 6;315(7108):600
references.pmid: 9302962
references.citation: Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003729
references.pmid: 15846678
references.citation: BMJ. 2007 Oct 27;335(7625):865
references.pmid: 17954514
references.citation: J Gen Intern Med. 1992 Nov-Dec;7(6):623-9
references.pmid: 1453246
references.citation: Psychol Med. 1972 Nov;2(4):422-5
references.pmid: 4656537
references.citation: Hosp Community Psychiatry. 1990 Jul;41(7):761-70
references.pmid: 2142118
references.citation: Psychiatr Q. 1964 Jan;38:42-63
references.pmid: 14148394
references.citation: Cochrane Database Syst Rev. 2006 Jul 19;(3):CD002084
references.pmid: 16855984
references.citation: Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006391
references.pmid: 17253592
references.citation: J Clin Exp Psychopathol Q Rev Psychiatry Neurol. 1961 Jul-Sep;22:151-62
references.pmid: 14498342
references.citation: Stat Med. 2002 Oct 15;21(19):2971-80
references.pmid: 12325113
references.citation: Acta Psychiatr Scand. 2000 Feb;101(2):87-103
references.pmid: 10706008
references.citation: Br J Psychiatry. 2004 Jul;185:63-9
references.pmid: 15231557
references.citation: Cochrane Database Syst Rev. 2007 Oct 17;(4):CD001943
references.pmid: 17943763
references.citation: Am J Psychiatry. 1960 May;116:973-80
references.pmid: 13791594
references.citation: Curr Ther Res Clin Exp. 1967 Aug;9(8):434-6
references.pmid: 4962467
references.citation: Health Technol Assess. 1999;3(5):iii-92
references.pmid: 10982317
references.citation: Lancet. 2001 Apr 14;357(9263):1191-4
references.pmid: 11323066
references.citation: Am J Psychiatry. 1982 Feb;139(2):212-5
references.pmid: 7055293
references.citation: Int J Epidemiol. 2002 Feb;31(1):140-9
references.pmid: 11914310
references.citation: BMJ. 1997 Sep 13;315(7109):629-34
references.pmid: 9310563
references.citation: Psychopharmacologia. 1965 Feb 15;7(2):89-106
references.pmid: 5318926
references.citation: Cochrane Database Syst Rev. 2004;(3):CD000525
references.pmid: 15266432
references.citation: BMJ. 2007 Jan 6;334 Suppl 1:s7
references.pmid: 17204765
references.citation: BMJ. 1996 Nov 9;313(7066):1200
references.pmid: 8916759
references.citation: BMJ. 2003 Sep 27;327(7417):708-13
references.pmid: 14512476
references.citation: Psychosomatics. 1973 Jan-Feb;14(1):59-63
references.pmid: 4605009
references.citation: Br J Psychiatry. 2000 Mar;176:249-52
references.pmid: 10755072
references.citation: Curr Ther Res Clin Exp. 1969 Dec;11(12):784-92
references.pmid: 4984044
references.citation: S Afr Med J. 1971 Aug 28;45(34):945-7
references.pmid: 4939661
references.citation: Am J Epidemiol. 1999 May 1;149(9):876-83
references.pmid: 10221325
references.citation: Cochrane Database Syst Rev. 2000;(2):CD001163
references.pmid: 10796606
references.citation: Synapse. 1987;1(2):133-52
references.pmid: 2905529
references.citation: Am J Psychiatry. 1964 Dec;121:597-600
references.pmid: 14239465
references.citation: J Nerv Ment Dis. 1988 Sep;176(9):558-61
references.pmid: 3418329
references.citation: Ann Clin Psychiatry. 2005 Jul-Sep;17(3):113-35
references.pmid: 16433053
references.citation: BMJ. 2007 Oct 27;335(7625):869
references.pmid: 17954515